FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLETS OF CANDESARTAN
Candesartan isÂ anÂ angiotensinÂ IIÂ receptor antagonistÂ andÂ isÂ widely Â usedÂ inÂ theÂ managementÂ ofÂ hypertensionÂ toÂ reduceÂ cardiovascular mortalityÂ in patients with leftÂ ventricularÂ dysfunctionÂ followingÂ myocardialÂ infarction,Â andÂ inÂ theÂ managementÂ ofÂ heartÂ failure. The Mucoadhesive buccal tablets were prepared by direct compression method using carbopol 934, HPMC K4M, sodium CMC as mucoadhesive polymer. The compatibility studies of drug and excipients were performed by FT-IR spectroscopy. After examining the flow properties of the powder blends the results are found to be within prescribed limits and indicated good flowing property, hence it was subjected to tablet compression. The tablets were evaluated for post-compression parameters like weight variation, hardness, thickness, friability, drug content uniformity, Surface pH, in-vitro studies like swelling, mucoadhesive strength and drug release. Formulation (F6) containing Carbopol-934 and Sodium CMC in the ratio of (2: 3) showed good mucoadhesive strength (36.14) and maximum drug release of 98.15% in 8 hrs. Swelling increases with increase in concentration of Sodium CMC in tablets. The drug content of shown highest of 99.15 %, Surface pH was found to be 6.42. All the evaluation parameters given the positive results and comply with the standards. Stability studies were carried out on the developed formulations indicated that the formulations were stable during the study period. The results indicate that the mucoadhesive buccal tablets of Candesartan may be good choice to bypass the extensive hepatic first pass metabolism with an improvement in the bioavailability of candesartan through buccal mucosa.
Key Words: Mucoadhesive buccal tablets, direct compression, Hypertension, Candesartan cilexetil,
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).